How are the critical relationships between chemical bioavailability, activity, and adversity established within an AOP in a way that protects the most sensitive subpopulations?

Rudel, R. How are the critical relationships between chemical bioavailability, activity, and adversity established within an AOP in a way that protects the most sensitive subpopulations? Adverse Outcome Pathways: From Research to Regulation. September 3-4, 2014, Bethesda, MD.

Related Research Area: